Adamis Pharmaceuticals Corp Business Operations Contracts & Agreements
13 Contracts & Agreements
- Agency Agreements (3 contracts)
- Development Agreements (1)
- Distribution Agreements (3)
- Sales Agreements (1)
- Settlement Agreements (1)
- Supply Agreements (1)
- Termination Agreements (1)
- Voting Agreements (2)
- Placement Agency Agreement (Filed With SEC on August 3, 2023)
- Sales Agreement (Filed With SEC on July 24, 2023)
- Settlement Agreement between the Company, US Compounding Inc., Nephron Pharmaceuticals Corporation, Nephron S.C., Inc., Nephron Sterile Compounding Center, LLC and certain other... (Filed With SEC on November 22, 2021)
- Supply Agreement Addendum by and among the Registrant, US Compounding, Inc. and Fagron Compounding Services, LLC (Filed With SEC on August 5, 2021)
- Distribution and Commercialization Agreement between the Company and USWM, LLC (Filed With SEC on August 17, 2020)
- *** Certain identified information hasbeen omitted from this exhibit because it is both (i) not material and (ii) would likely cause competitive harm to the Registrantif publicly... (Filed With SEC on August 17, 2020)
- Placement Agency Agreement (Filed With SEC on February 21, 2020)
- Distribution and Commercialization Agreement between the Company and Sandoz, Inc (Filed With SEC on November 9, 2018)
- Placement Agency Agreement dated July 29, 2016 (Filed With SEC on July 29, 2016)
- PRODUCT DEVELOPMENT & CONTRACT MANUFACTURING AGREEMENT Adamis Pharmaceuticals Corp., USA and Beximco Pharmaceuticals Ltd., Bangladesh (Filed With SEC on February 14, 2011)
- VOTING AGREEMENT (Filed With SEC on November 13, 2008)
- VOTING AGREEMENT (Filed With SEC on February 13, 2008)
- EXCLUSIVELICENSE AND DISTRIBUTION AGREEMENT FOR RECTOGESIC BETWEEN STRAKANINTERNATIONAL LIMITED AND CELLEGYPHARMACEUTICALS, INC. CONFIDENTIAL (Filed With SEC on March 31, 2005)
